Thank you for claiming your business. Kindly check your Email for verification mail from Sulekha.com Our team will contact you shortly!.
About Clovis Oncology
We are a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our development programs are targeted at specific subsets of cancer, combining precision medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from them.We have one marketed product, Rubraca® (rucaparib) tablets. For information on our marketed product, click here. Rucaparib is in advanced clinical development for the treatment of ovarian cancer and we are initiating clinical development for the treatment of metastatic castration-resistant prostate cancer patients. We maintain global rights to rucaparib. For more program details, see key events timeline below.
